For instance, individuals with inflammatory bowel diseases (IBD) (Lamas et al., 2016), the metabolic syndrome (Natividad et al., 2018) or celiac disease (Lamas et al., 2020) have decreased fecal concentrations of AhR ligands and reduced AhR activity. Here, AHR is linked to metabolic syndrome.